Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
A series of novel 2-arylbenzoxazoles that upregulate the production of utrophin in murine H2K cells, as assessed using a luciferase reporter linked assay, have been identified. This compound class appears to hold considerable promise as a potential treatment for Duchenne muscular dystrophy. Followin...
Main Authors: | Chancellor, DR, Davies, K, De Moor, O, Dorgan, C, Johnson, P, Lambert, A, Lawrence, D, Lecci, C, Maillol, C, Middleton, P, Nugent, G, Poignant, S, Potter, A, Price, P, Pye, R, Storer, R, Tinsley, J, van Well, R, Vickers, R, Vile, J, Wilkes, F, Wilson, F, Wren, S, Wynne, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Utrophin upregulation in Duchenne muscular dystrophy.
by: Hirst, R, et al.
Published: (2005) -
Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2012) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
by: Potter, A, et al.
Published: (2006) -
Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
by: Fairclough, R, et al.
Published: (2008) -
Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research
by: Bareja, A
Published: (2011)